Quantcast
Last updated on May 23, 2013 at 21:22 EDT

Latest Progesterone Stories

2013-05-17 13:25:53

New research indicates that women’s reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females. The study appears in the American Journal of Human Biology. An animal’s energetic resources must be carefully allocated, said University of Illinois anthropology professor Kathryn Clancy, who led the new research. The body’s first priority is maintenance, which includes tasks inherently related to survival,...

2013-05-15 20:23:06

-- Data suggest presence of activated progesterone receptors in cells predict anti-progestin efficacy in endometrial and breast cancers; support further evaluation of onapristone FLEMINGTON, N.J., May 15, 2013 /PRNewswire/ -- Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced new, positive data from three studies supporting its investigational compound onapristone to be presented at...

2013-04-18 08:30:27

Investigational Treatment for Mild Traumatic Brain Injury to be Studied in Phase I Trial Later This Year BANGKOK, April 18, 2013 /PRNewswire-USNewswire/ -- Besins Healthcare (Besins) and Shin Nippon Biomedical Laboratories (SNBL), a global leader in hormonal products, announced today that they have completed a licensing agreement to use SNBL's proprietary intranasal drug delivery system, Muco(TM) System, to further develop its BHR-310 investigational agent containing progesterone for...

2013-04-15 12:28:42

Study Evaluating Intravenous Progesterone Formulation BHR-100 Aims to Bring First-Ever Approved TBI Treatment to Market; Patient Enrollment Set to Complete in 2013 HERNDON, Va., April 15, 2013 /PRNewswire-USNewswire/ -- BHR Pharma, LLC announced today that the 1,000(th) patient has been enrolled in its SyNAPSe® clinical trial, a global phase III study evaluating the effectiveness of its proprietary intravenous progesterone infusion agent, BHR-100, to treat severe traumatic brain...

2013-03-05 12:28:54

Five Scientists Aim to Make Strides in Predicting and Preventing Preterm Birth WHITE PLAINS, N.Y., March 5, 2013 /PRNewswire-USNewswire/ -- Five researchers from four states are investigating how genetics and infections interact to cause preterm birth as well as how proteins and hormones regulate a healthy pregnancy, all with the goal of giving more babies a healthy start in life, the March of Dimes announced today. The researchers will study the role that fetal fibronectin, a...

2013-01-17 08:26:46

HERNDON, Va., Jan. 17, 2013 /PRNewswire/ -- BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion. The SyNAPSe® Trial is evaluating BHR-100, a proprietary intravenous progesterone lipid emulsion product as a neuroprotective agent to treat severe traumatic brain injury...

2012-11-16 14:21:21

Global partners challenge 39 high-income countries Lowering preterm birth rates by an average of 5 percent across 39 high-resource countries, including the United States, by 2015 would prevent prematurity for 58,000 babies a year, a group of international experts said today. In an article published in The Lancet to coincide with the second annual World Prematurity Day, the expert group say prevention of preterm birth also could save billions in economic costs. "Governments and health...

2012-11-15 20:21:12

Global Partners Challenge 39 High-Income Countries WHITE PLAINS, N.Y., Nov. 15, 2012 /PRNewswire-USNewswire/ -- Lowering preterm birth rates by an average of 5 percent across 39 high-resource countries, including the United States, by 2015 would prevent prematurity for 58,000 babies a year, a group of international experts said today. In an article published in The Lancet to coincide with the second annual World Prematurity Day, the expert group say prevention of preterm birth also...

Hormone And Breastfeeding Impacts On Breast Cancer
2012-10-19 04:50:43

Connie K. Ho for redOrbit.com – Your Universe Online While phrases like “I love Big Bird” and “binders full of woman” are tidbits that people remember about the past two presidential candidate debates, another facet of the debates is the clothing that the spouses of the presidential candidates wear. In this past week’s debate, both Michelle Obama and Ann Romney chose to wear the striking color of pink. The color reflects October as breast cancer awareness month. While awareness...

2012-10-03 10:24:14

Kronos Early Estrogen Prevention Study results to help clinicians assess HT risk-benefits PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Kronos Longevity Research Institute (KLRI) today announced that a major finding of the Kronos Early Estrogen Prevention Study (KEEPS) indicates that hormone therapy (HT) improves symptoms of depression and anxiety in recently menopausal women, without adverse effects on cognition. The findings come as a result of a four-year randomized clinical...